All In Biotech

Drug Trial Radar · NCT00228553

Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness

A 12-Month, Open-Label, Flexible-Dosage (100 to 250 mg/Day) Extension Study of the Safety and Efficacy of Armodafinil (CEP-10953) in the Treatment of Patients With Excessive Sleepiness Associated With Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (With an Open-Ended Extension Period)

Last checked: Nov 20, 2026Latest source record: Jul 19, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

743

Actual

Start

May 2004

Primary completion

Not stated

Study completion Jul 2006

Sponsor

Lead sponsor
CephalonIndustry
Sponsor type
Industry
First posted
Sep 29, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Factorial
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A 12 Month, Open-Label, Flexible Dosage Extension Study of the Safety and Efficacy of Armodafinil (CEP-10953) in the Treatment of Patients with Excessive Sleepiness Associated with Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

Conditions

  • Excessive Daytime Sleepiness
  • Narcolepsy
  • Obstructive Sleep Apnea/Hypopnea Syndrome
  • Chronic Shift Work Sleep Disorder

Interventions

  • Armodafinil 100 to 250 mg/dayDrug

    Armodafinil 100-250 mg: once daily in the morning for patients with obstructive sleep apnea/hypopnea syndrome (OSAHS) or narcolepsy, once daily only on nights worked for patients with shift worker sleep disorder (SWSD).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and Tolerability in This Patient Population (Narcolepsy, OSAHS, SWSD) Over Time (up to 2 Years)Time frame: End of months 1, 3, 6, 9, and 12 and every 3 months for up to an additional year

Locations

100 sites in 7 countries. Site status is shown where the registry gives one.

  • Sleep Disorders Ctr of Alabama

    Birmingham, Alabama

  • Pulmonary Associates, PA

    Phoenix, Arizona

  • Psypharma Clinical Research

    Phoenix, Arizona

  • Central Arkansas Research

    Hot Springs, Arkansas

  • Advanced Clinical Research Ins

    Anaheim, California

  • Southwestern Research

    Beverly Hills, California

  • Pacific Sleep Medicine Service

    Los Angeles, California

  • Pacific Sleep Medicine Service

    Palm Springs, California

  • Radiant Research San Diego

    San Diego, California

  • Pacific Sleep Medicine Service

    San Diego, California

  • BMR HealthQuest

    San Diego, California

  • Sleep Clinic of San Francisco

    San Francisco, California

  • St. Johns Medical Plaza Sleep

    Santa Monica, California

  • Stanford University

    Stanford, California

  • PAB Clinical Research

    Brandon, Florida

  • St. Petersburg Sleep Disorder

    St. Petersburg, Florida

  • Sleep-Wake Disorder Center

    Winter Park, Florida

  • Neurotrials Research

    Atlanta, Georgia

  • Sleep Disorders Center of GA

    Atlanta, Georgia

  • SLEEPMED, Inc.

    Macon, Georgia

  • Radiant Research Marietta

    Marietta, Georgia

  • Henry Lahmeyer, MD

    Northfield, Illinois

  • Peoria Pulmonary Associates

    Peoria, Illinois

  • Center for Sleep Disorders

    Danville, Indiana

  • University of Iowa Hospitals

    Iowa City, Iowa

  • Vince and Associates Clinical

    Overland Park, Kansas

  • Topeka Pulmonary

    Topeka, Kansas

  • Graves Gilbert Clinic

    Bowling Green, Kentucky

  • Community Research

    Crestview, Kentucky

  • Chest Medicine Associates DBA

    Louisville, Kentucky

  • Neurotrials Research of New Or

    Metairie, Louisiana

  • Northshore Research Associates

    Slidell, Louisiana

  • Center for Sleep/Wake Disorder

    Chevy Chase, Maryland

  • Regional Pulmonary and Sleep

    Elkton, Maryland

  • McLean Hospital

    Belmont, Massachusetts

  • Neurocare, Inc.

    Newton, Massachusetts

  • Sleep Disorders Center

    Hattiesburg, Mississippi

  • Washington University School o

    St Louis, Missouri

  • Clinical Rsch Center of Nevada

    Las Vegas, Nevada

  • CNS Research Institute

    Clementon, New Jersey

Showing 40 of 100 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.